4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

In this section of the European Resuscitation Council Guidelines 2021, key information on
the epidemiology and outcome of in and out of hospital cardiac arrest are presented. Key …

Sudden cardiac death (SCD) is the leading cause of mortality in athletes during sport. A
variety of mostly hereditary, structural, or electrical cardiac disorders are associated with …

The J-wave syndromes (JWSs), consisting of the Brugada syndrome (BrS) and early
repolarization syndrome (ERS), have captured the interest of the cardiology community over …

The Brugada syndrome is an inherited disorder associated with risk of ventricular fibrillation
and sudden cardiac death in a structurally normal heart. Diagnosis is based on a …

In this scientific statement from the American Heart Association, experts in the field of
cardiomyopathy (heart muscle disease) in children address 2 issues: the most current …

Sudden cardiac death (SCD) is the leading cause of mortality in athletes during sport. A
variety of mostly hereditary, structural or electrical cardiac disorders are associated with …

This international consensus statement is the collaborative effort of three medical societies
representing electrophysiology in North America, Europe and Asian-Pacific area: the Heart …

Cardiovascular implantable electronic devices (CIEDs) have evolved significantly since the
publication of the 2008 Heart Rhythm Society (HRS) consensus statement 1 outlining …